Trial NCT01232556

View at ClinicalTrials.gov 
Org. Study IDs: B1931008
Secondary IDs: 2010-020147-12 3129K5-3303

Last trial update was posted on 2019-01-08

MeSH Interventions

Bendamustine Hydrochloride Gemcitabine Inotuzumab Ozogamicin Rituximab

MeSH Conditions

Aggression Lymphoma Lymphoma, Non-Hodgkin

Other Conditions


Stopping Reasons

The study was terminated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.

Limitations And Caveats

Interpretation of the results is limited by the small number of subjects analyzed and follow-up period was shortened due to the early termination of the study. Adverse Events were calculated using the safety populations.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID